Skip to content
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision, mission & strategy
Products
Psyros
®
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision, mission & strategy
Products
Psyros
®
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
EN
SV
Press releases
Category
All
Regulatory
Non-Regulatory
Interim
Annual
Year
All
2026
2025
2024
2023
2022
2025
2025-12-18 08:20
Biostock publishes an article about the key milestone toward commercialisation - assay design freeze
2025-12-17 08:00
Prolight Diagnostics achieves assay design freeze for Psyros™ point-of-care cartridge – A key milestone toward commercialisation
2025-12-11 08:30
Prolight secures third patent in Europe for Psyros™
2025-12-08 09:30
BioStock publishes an article describing how Prolight Diagnostics is preparing the clinical study
2025-12-05 11:00
THE NOMINATION COMMITTEE APPOINTED FOR THE ANNUAL GENERAL MEETING 2026
Regulatory
2025-12-04 10:00
Prolight announces timetable for share reverse split
Regulatory
2025-11-27 08:00
Prolight Diagnostics publishes quarterly report Q3, 2025
Regulatory
MAR
2025-11-19 14:45
Extraordinary general meeting of Prolight Diagnostics AB (publ) on 19 November 2025
Regulatory
2025-11-17 12:40
BioStock publishes article about Prolight Diagnostics continued preparations to bring the Psyros platform to market
2025-11-05 14:55
Prolight Diagnostics publishes investor letter for November 2025
Previous
Next
